APA (7th ed.) Citation

Topkan, E., Kucuk, A., & Selek, U. Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide. Wiley.

Chicago Style (17th ed.) Citation

Topkan, Erkan, Ahmet Kucuk, and Ugur Selek. Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide. Wiley.

MLA (9th ed.) Citation

Topkan, Erkan, et al. Pretreatment Pan-Immune-Inflammation Value Efficiently Predicts Survival Outcomes in Glioblastoma Multiforme Patients Receiving Radiotherapy and Temozolomide. Wiley.